76
Overbought
Moving averages
SMA 200$190.03+55.34%
Company profile
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$13.58B
P/E ratioNone
EPS$-4.82
Beta1.376
Dividend yield0.00%
52-week high$287.95
52-week low$144.26
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 75
ILMN
Illumina Inc
RSI 70
MTD
Mettler-Toledo International Inc
RSI 54
CSTL
Castle Biosciences Inc
RSI 71
FONR
Fonar Corp
RSI 75
BDSX
Biodesix Inc
RSI 64
NTRA
Natera Inc
RSI 72
WGS
GeneDx Holdings Corp - Class A
RSI 71
DGX
Quest Diagnostics Inc
RSI 36
NEO
Neogenomics Inc
RSI 35
RSI alerts for CRL
Get an email the moment Charles River Laboratories crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 10:28 PM EDT